2016
DOI: 10.1080/13543776.2016.1215434
|View full text |Cite
|
Sign up to set email alerts
|

Synthetic drugs for the treatment of vitiligo: a patent review (2010–2015)

Abstract: In conclusion, we found significant advancement in this field of research, demonstrating the growing interest of academic and industrial groups in developing successful products for the treatment of vitiligo. New therapeutic options could contribute to improving the quality of life of patients and advance the search for a truly effective treatment of vitiligo.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
6
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 39 publications
0
6
0
Order By: Relevance
“…Currently available treatment options for diabetes mellitus are achieved through oral hypoglycemic agents (metformin, sulfonylureas, and thiazolidinediones), insulin therapy, dietary guidance, and regular physical activity [7,8]. Unfortunately, their use is limited by adverse effects including gastrointestinal disorders, hypoglycemia, pancreatic degeneration, liver damage in the body [9], failure to achieve glycemic control, a different drug response among individuals [8,10] and cardiovascular disorders [9].…”
Section: Introductionmentioning
confidence: 99%
“…Currently available treatment options for diabetes mellitus are achieved through oral hypoglycemic agents (metformin, sulfonylureas, and thiazolidinediones), insulin therapy, dietary guidance, and regular physical activity [7,8]. Unfortunately, their use is limited by adverse effects including gastrointestinal disorders, hypoglycemia, pancreatic degeneration, liver damage in the body [9], failure to achieve glycemic control, a different drug response among individuals [8,10] and cardiovascular disorders [9].…”
Section: Introductionmentioning
confidence: 99%
“…3 The treatment of vitiligo, despite many available options, is still a challenge because of numerous reported relapses or incomplete re-pigmentation. 13,14 The main characteristic of vitiligo is presence of asymptomatic depigmented macules or patches with sharp margins caused by the destruction of melanin and melanocytes of the skin. 15 Although the exact cause of vitiligo is obscure, three proposed pathogenetic mechanisms include the immune hypothesis (melanocyte dysfunction or destruction due to the immune surveillance defect), the neural hypothesis (destroying melanocytes or inhibiting melanin production by a neurochemical mediator), and the selfdestruction hypothesis (melanocyte abnormalities caused by an intermediate or metabolite of melanin production).…”
Section: Introductionmentioning
confidence: 99%
“…The treatment of vitiligo, despite many available options, is still a challenge because of numerous reported relapses or incomplete re‐pigmentation 13,14 . The main characteristic of vitiligo is presence of asymptomatic depigmented macules or patches with sharp margins caused by the destruction of melanin and melanocytes of the skin 15 …”
Section: Introductionmentioning
confidence: 99%
“…Current therapeutic drugs of vitiligo focus on skin repigmentation in a way of phenotypic intervention, such as immunomodulators (glucocorticoids) and calcineurin inhibitors (tacrolimus and pimecrolimus) ( Iannella et al, 2016 ). However, these drugs are not satisfactory to many patients because of time-consuming and adverse reactions ( Picardo et al, 2015 ; de Menezes et al, 2016 ; Iannella et al, 2016 ). One possible reason is that these therapeutic drugs are single-target treatments, rather than multi-target strategy under the network pharmacology ( Hopkins, 2008 ).…”
Section: Introductionmentioning
confidence: 99%